Terms: = Breast cancer AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4
9 results:
1. The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients.
Montagna E; Pagan E; Cancello G; Sangalli C; Bagnardi V; Munzone E; Salè EO; Malengo D; Cazzaniga ME; Negri M; Peruzzotti G; Veronesi P; Viale G; Colleoni M
Anticancer Drugs; 2022 Jan; 33(1):e628-e634. PubMed ID: 34407044
[TBL] [Abstract] [Full Text] [Related]
2. The economic impact of disease progression and death in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data.
Park SK; Park JA; Yang SY; Shin JY; Koh H
Curr Med Res Opin; 2020 Nov; 36(11):1825-1833. PubMed ID: 32965131
[TBL] [Abstract] [Full Text] [Related]
3. A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation.
Burleigh A; McKinney S; Brimhall J; Yap D; Eirew P; Poon S; Ng V; Wan A; Prentice L; Annab L; Barrett JC; Caldas C; Eaves C; Aparicio S
Breast Cancer Res; 2015 Jan; 17():4. PubMed ID: 25572802
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.
Metzger-Filho O; de Azambuja E; Bradbury I; Saini KS; Bines J; Simon SD; Dooren VV; Aktan G; Pritchard KI; Wolff AC; Smith I; Jackisch C; Lang I; Untch M; Boyle F; Xu B; Baselga J; Perez EA; Piccart-Gebhart M
Oncologist; 2013; 18(2):134-40. PubMed ID: 23359433
[TBL] [Abstract] [Full Text] [Related]
5. Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
Wagner V; Stadelmeyer E; Riederer M; Regitnig P; Gorischek A; Devaney T; Schmidt K; Tritthart HA; Hirschberg K; Bauernhofer T; Schreibmayer W
J Cell Biochem; 2010 Jun; 110(3):598-608. PubMed ID: 20512921
[TBL] [Abstract] [Full Text] [Related]
6. Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells.
Dhar MS; Plummer HK
BMC Physiol; 2006 Aug; 6():8. PubMed ID: 16945134
[TBL] [Abstract] [Full Text] [Related]
7. Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines.
Plummer HK; Yu Q; Cakir Y; Schuller HM
BMC Cancer; 2004 Dec; 4():93. PubMed ID: 15603589
[TBL] [Abstract] [Full Text] [Related]
8. Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Wierik EJ; Hendricks PT; Boerstoel-Streefland M
Climacteric; 2004 Jun; 7(2):197-209. PubMed ID: 15497909
[TBL] [Abstract] [Full Text] [Related]
9. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.
Anderson DC; Nichols E; Manger R; Woodle D; Barry M; Fritzberg AR
Biochem Biophys Res Commun; 1993 Jul; 194(2):876-84. PubMed ID: 8343170
[TBL] [Abstract] [Full Text] [Related]
